Approved COVID-19 Biospecimen Protocols
Name/TitleDescriptionSamples collectedClinical data
WU350 (IRB#202003085)

Immunological, genetics and clinical predictors of SARS CoV-2 infection
ED and inpatient based recruitment, with samples collected at up to 6 time points (0,3,7,14,28,84). Follow-up outpatient in ID clinic
(Goal recruitment=300)
Plasma
Serum
PaxGene
Cryopreserved Cells
Urine
Saliva

Location: Tissue Procurement Core
REDCap and I2 DataCommons
WU353 (IRB# 202003186)

Registry and screening of participants with history of confirmed SARS CoV-2 infection to evaluate for eligibility for donation of convalescent plasma
Donor plasma protocol, single time point (Goal=5/d)Plasma
Serum
Cryopreserved Cells

Location: Tissue Procurement Core
REDCap and I2 DataCommons
OB/GYN (IRB# 202003130)

Course of COVID-19 Infection in Pregnancy
Inpatient and outpatient collection from pregnant women and infantsBlood
Saliva
NP swabs
Urine
amniotic fluid

Location: WIHSC
REDCap
RADx-UP WUIDDRC (IRB# 202009060)

Supporting the health and well-being of children during the COVID-19 pandemic
Weekly samples from participantsSaliva

Location: IDDRC
Not applicable

Contact:
gurnettc@wustl.edu
IRB# 202006151

Linking inflammatory phenotypes and biomarkers to trajectories and outcomes in patients with COVID-19-related Acute Respiratory Distress Syndrome (ARDS)
Mechanically ventilated

patients with paired BAL and plasma samples collected
BAL, serumNot applicable

Contact: m.c.vazquezguillamet@wustl.edu
Process for Obtaining Biospecimens
Funding Acknowledgement for COVID-19 Biorepository

Any publication that used samples from the Washington University COVID-19 biorepository must cite the following support:

“This study utilized samples obtained from the Washington University School of Medicine’s COVID-19 biorepository, which is supported by: the Barnes-Jewish Hospital Foundation; the Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health; and the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH.” 

In addition, the publication must recognize the role of the investigators who developed and maintained the biorepository  – Jane O’Halloran, MD, PhD; Rachel Presti, MD, PhD, Charles Goss, PhD, and Phillip Mudd, MD, PhD.  Recognition can be in the form of co-authorship or acknowledgement, whichever is most appropriate.